You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Ximelagatran reduced venous thromboembolism more than warfarin after total knee replacement

https://doi.org/10.1136/ebm.9.4.106

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • ↵* See glossary.

    • ↵† Information provided by author.

    • For correspondence: Dr C W Francis, University of Rochester, Rochester, NY, USA. charles_francisurmc.rochester.edu

    • Source of funding: AstraZeneca.

    • Abstract and commentary also appear in ACP Journal Club.